Related Experiment Video
Updated: Dec 13, 2025

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Prevalence of Acute Hypersensitivity Reactions in Pediatric Patients Receiving Crotalidae Polyvalent Immune Fab
Bryan Corbett1, Jenna Otter2, Clifford P Masom3
1Division of Medical Toxicology, Department of Emergency Medicine, UC San Diego Health, 200 West Arbor Drive #8676, San Diego, CA, 92103, USA. bcorbett@health.ucsd.edu.
Insights
Acute hypersensitivity reactions to Crotalidae Polyvalent Immune Fab (CPIF) were not observed in pediatric patients. This study indicates that such adverse events are rare in children treated for snakebites.
Area of Science:
- Pediatric Toxicology
- Pharmacovigilance
- Allergy and Immunology
Background:
- Acute hypersensitivity reactions to Crotalidae Polyvalent Immune Fab (CPIF) pose a challenge in pediatric populations due to variations in patient size, age, and reaction definitions.
- Understanding the incidence of these reactions is crucial for safe and effective treatment of Crotalid envenomation in children.
Purpose of the Study:
- To evaluate the occurrence of acute hypersensitivity reactions following CPIF administration in pediatric patients.
- To define and assess the incidence of specific hypersensitivity symptoms within a defined timeframe after CPIF initiation.
Main Methods:
- A retrospective chart review was conducted on pediatric patients (≤13 years) treated with CPIF for Crotalid envenomation between November 2006 and 2016.
- Data collected included demographics, CPIF dosage, bite details, ICU admission, length of stay, and the presence of hypersensitivity symptoms (urticaria, respiratory distress, angioedema, hypotension, nausea, vomiting) within 3 hours of infusion.
Main Results:
- Thirty-four pediatric patients received CPIF, with ages ranging from 10 months to 13 years.
- No patients in this cohort developed acute hypersensitivity reactions to CPIF.
- The majority of patients (70.6%) required intensive care unit admission, with a median hospital stay of 2 days.
Conclusions:
- Acute hypersensitivity reactions to CPIF were not observed in this cohort of pediatric patients.
- The findings suggest that CPIF is well-tolerated in children, with hypersensitivity reactions being a rare occurrence.
Introduction:
Studies of acute hypersensitivity reactions in pediatric populations receiving Crotalidae Polyvalent Immune Fab (CPIF) are complicated by small size, wide age ranges, and diverse definitions of such reactions.
Methods:
This is a retrospective chart review of patients aged 13 years or younger treated with CPIF for Crotalid envenomation from November 2006 to 2016. The primary outcome was the presence of an acute hypersensitivity reaction to CPIF and was defined as the development of any of the following symptoms within 3 hours of initiation of CPIF infusion: urticaria, wheezing or respiratory distress, angioedema, hypotension, nausea, and/or vomiting. Demographics, CPIF dose to control and total dose, bite location, level of care, and length of stay were also recorded.
Results:
Thirty-four patients were ultimately treated with CPIF. Ages ranged from 10 months to 13 years. Twenty-one patients (60%) were male, 24 (70.6%) were admitted to the ICU, and the median length of stay was 2 days with a range of 1-11 days. Zero patients developed an acute hypersensitivity reaction to CPIF.
Conclusion:
Acute hypersensitivity reactions to CPIF did not occur in this cohort. Such reactions are rare with the use of CPIF in pediatric patients.
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Reactions
Allergic Drug Reactions
Cross-reactivity
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion

